The oral Wegovy pill allows those hesitant about injections to benefit from semaglutide treatment
General qualifying criteria include: Adults with a BMI of 30 or higher (clinical obesity), or BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol Adults who have not achieved adequate weight loss through diet and lifestyle changes alone Patients without a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 Patients who are not pregnant or planning pregnancy Patients without a history of pancreatitis (assessed case by case) At your consultation, Tiffany reviews your health history, discusses your weight loss goals and previous experiences, and determines whether GLP-1 therapy is appropriate for you and which medication and dosing approach makes the most sense
Lipotropic compounds help support the livers natural ability to break down fat and convert it into usable energy
Medical contributors: thyroid disease, anemia, low B12, or chronic pain
Supplied in lyophilised form, each vial is prepared to support precise handling, stability, and reproducibility within research settings
Clinical trials and real-world data show that gastrointestinal side effectsincluding nausea, vomiting, and refluxoccur in a meaningful proportion of GLP-1 users
